Cinctive Capital Management LP Gilead Sciences, Inc. Transaction History

Cinctive Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $3.67 Million - $4.13 Million	63,520 New	63,520 $3.93 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $13.7 Million - $14.7 Million	-201,779 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $12.8 Million - $14 Million	201,779 New	201,779 $13.9 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $8.57 Million - $11 Million	-136,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $8.43 Million - $9.27 Million	136,800 New	136,800 $8.89 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.